Senior Director, Radiotracer Supply Strategy and External Engagement
Eli LillyAt Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us. At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world. Position Overview: Leads the global Drug Product supply strategy for diagnostic radiotracers enabling development and commercialization of therapeutic medicines. The role is responsible for defining the supply strategy that connects the clinical trial design with radiotracer availability (geography and manufacturing capacity). Accountable for capacity planning, network expansion, supply risk and continuity, cost-of-goods, and reliable dose fulfillment across geographies, in partnership with Manufacturing Operations teams, CDDA, the Therapeutic Area Business Units, Procurement, Quality, and external partners. Primary Responsibilities: This position will provide leadership, direction, and management of the global radiotracer supply strategy. The individual will provide expertise and leadership in the supply of new radiopharmaceutical products working in a fast-paced, multi-disciplinary environment. Define and own the global radiotracer supply strategy and ensure the strategy meets the needs for clinical trial and commercial endeavors in collaboration with Clinical Design, Delivery, & Analytics (CDDA) and the Therapeutic Area Business Units as applicable. Set the multi-year strategy for expanding global radiotracer manufacturing capacity across CMOs and radiopharmacies, balancing demand, cost, geographic coverage, and supply risk. Partner with digital and data teams to embed AI-enabled capabilities (for example, scenario planning, supplier performance analytics, and early-warning risk signals) into supply strategy and governance processes. Establish supply governance and proactively communicate radiotracer supply status and changes in supply (including risks and mitigation plans) within radiopharm and PRD leadership and other stakeholder groups (e.g CDDA and the Therapeutic Area Business Units) as needed. Build and sustain strategic relationships with CDDA and Therapeutic Area Business Unit leadership, partnering early in program planning to align on supply priorities, trade-offs, and timelines. Evaluate the radiotracer environment in geographies of interest to understand capacity, regulatory and licensing requirements, transport constraints, and partnership opportunities. Navigate regional regulatory, radioactive material licensing, import/export, and transport requirements to enable reliable supply in new geographies. Lead, develop, and build the capabilities of the supply strategy organization across sites, geographies, and time zones. Identify new potential CMOs, manufacturing sites and / or radiopharmacies with capacity to manufacture and/or prepare diagnostic radiotracer(s) in geographies of interest as needed to support demand. Define the business requirements CMO or radiopharmacy supply agreements and/or Third Party Organization Sponsors and approve…